retatrutide clinical trial effects Side 2026 retatrutide parkinson's clinical trial Effects

Additionally, GLP-1 receptor agonists as a group were associated with a lower risk of self-harm

allow to dry

Patients were excluded if they had a major cardiovascular event within the last 60 days, type 1 diabetes mellitus, history of pancreatitis, or a history of severe hypoglycemia

Overdosing is a big concern The FDA also issued a warning about overdoses of compounded semaglutide in late July

Possible safety discussions may include gastrointestinal symptoms, dehydration risk, gallbladder history, pancreatitis history, kidney function, pregnancy plans, and current medicines

Jamy Ard leads the medical program, which also includes dietitian visits and behavioral counseling